Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.74 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.74 |
| ▸ | OSBP | P22059 | 1/20 | 0.74 |
| ▸ | RORC | P51449 | 1/20 | 0.74 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.74 |
| ▸ | GRIN1 | Q05586 | 15/20 | 0.68 |
| ▸ | GRIN2B | Q13224 | 15/20 | 0.68 |
| ▸ | GRIN2A | Q12879 | 13/20 | 0.67 |
| ▸ | POLA1 | P09884 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2185461 | 1.00 | USP2 (0.74) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL932623 | 1.00 | USP2 (0.74) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL4961477 | 0.92 | GRIN1 (0.80) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL5935410 | 0.92 | GRIN1 (0.80) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL21822074 | 0.91 | OSBP (0.75) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL10887781 | 0.90 | USP2 (0.71) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL8930167 | 0.90 | USP2 (0.71) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL18529717 | 0.90 | USP2 (0.71) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL720338 | 0.90 | USP2 (0.71) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL10943687 | 0.90 | USP2 (0.71) | USP2CYP46A1LMNAABCB1OSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2241 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139254-A1 | INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF | JENKEM TECH CO LTD BEIJING (CN) | 2026-05-21 | — | — | US | claimed |
| CN-122059896-A | Ionizable lipid gene vector and organ selective regulation method | 南开大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122028909-A | Lipid nanoparticles with non-covalent bifunctional conjugates for active targeting | 莫特治疗股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4721759-A1 | LIPID NANOPARTICLE FOR DELIVERING NUCLEIC ACID DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Cansino (Shanghai) Biological Research Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4707289-A1 | STEROID-CATIONIC LIPID COMPOUND AND USE THEREOF | Cansino (Shanghai) Biological Research Co., Ltd. (CN) | 2026-03-11 | — | — | EP | claimed |
| EP-4342929-B1 | POLYETHYLENE GLYCOL LIPID AND USE THEREOF | JENKEM TECH CO LTD TIANJIN (CN) | 2026-02-04 | — | — | EP | claimed |
| EP-4365168-B1 | POLYOL-MODIFIED LIPID COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF | JENKEM TECH CO LTD TIANJIN (CN) | 2025-10-15 | — | — | EP | claimed |
| US-20250313844-A1 | INTERFERING RNA FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2025-10-09 | — | — | US | claimed |
| EP-4628496-A1 | STEROID-CATIONIC LIPID COMPOUND AND USE THEREOF | Jenkem Technology Co., Ltd. (Liaoning) (CN) | 2025-10-08 | — | — | EP | claimed |
| WO-2000078972-A2 | REGULATION WITH BINDING CASSETTE TRANSPORTER PROTEIN ABC1 | CV THERAPEUTICS, INC. (US) | 2000-12-28 | — | — | WO | claimed |
| WO-1999058549-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-11-18 | — | — | WO | claimed |
| EP-0855445-A1 | PROCESS FOR PRODUCING HYDROXYLATED CHOLESTEROLS BY BIOLOGICAL CONVERSION AND DIHYDROXYCHOLESTEROLS | MERCIAN CORPORATION (JP) | 1998-07-29 | — | — | EP | claimed |
| EP-0540649-A1 | METHOD FOR HYDROXYLATION OF A CYCLIC OR ACYCLIC METHYLENE RADICAL IN THE ALLYLIC POSITION, PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYCHOLESTEROL DERIVATIVES AND UTILISATION OF SUCH COMPOSITIONS FOR THE PREPARATION OF DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1993-05-12 | — | — | EP | claimed |
| WO-1992001803-A1 | METHOD FOR HYDROXYLATION OF A CYCLIC OR ACYCLIC METHYLENE RADICAL IN THE ALLYLIC POSITION, PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYCHOLESTEROL DERIVATIVES AND UTILISATION OF SUCH COMPOSITIONS FOR THE PREPARATION OF DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1992-02-06 | — | — | WO | claimed |
| EP-0258434-A4 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL. | JAVITT NORMAN B (US) | 1989-11-07 | — | — | EP | claimed |
| EP-0258434-A1 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL | JAVITT, Norman B. (US) | 1988-03-09 | — | — | EP | claimed |
| WO-1987004346-A1 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL AND USE THEREOF FOR TOPICAL TREATMENT OF DISEASES | JAVITT NORMAN B | 1987-07-30 | — | — | WO | claimed |
| US-4496482-A | FROM ISOCYANATOSILANES, FOR BONDING TO SUBSTRATES | UNION CARBIDE CORPORATION (US) | 1985-01-29 | — | — | US | claimed |
| US-4224319-A | AMINO ACID, TRIGLYCERIDE, VITAMINS A AND E | MARCADET ERNEST | 1980-09-23 | — | — | US | claimed |